Market Place
Sourcing Support
AstraZeneca boosts China presence with FibroGen`s anemia drug in $160M deal
21 Feb 2025 //
REUTERS
Astrazeneca Pharma India Net Profit Rises 95.25% In Q3
12 Feb 2025 //
BUSINESS STD
Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr
12 Feb 2025 //
BUSINESS STD
AZ’s Alexion creates interactive storybook for kids with aHUS
12 Feb 2025 //
FIERCE PHARMA
AIM Plans Study Of Ampligen® & FluMist® For Avian Influenza
07 Feb 2025 //
GLOBENEWSWIRE
AstraZeneca CEO defends `fantastic` Alexion buy as halts drug
07 Feb 2025 //
FIERCE BIOTECH
AstraZeneca shares rise as China probe update reassures
07 Feb 2025 //
REUTERS
AstraZeneca`s Full Year and Q4 2024 results
06 Feb 2025 //
BUSINESSWIRE
AstraZeneca shareholders say need clarity on China investigations
05 Feb 2025 //
REUTERS
Erasmus Safety Committee Approves Ph 2 Study for Pancreatic Cancer
05 Feb 2025 //
GLOBENEWSWIRE
UK hits back at AstraZeneca over collapse of investment deal
04 Feb 2025 //
REUTERS
AZ scraps £450M vaccine plant expansion in the UK
01 Feb 2025 //
FIERCE PHARMA
AstraZeneca ditches UK investment over cut in state support
31 Jan 2025 //
REUTERS
Datopotamab Deruxtecan Recommended For Approval In EU By CHMP
31 Jan 2025 //
BUSINESSWIRE
Tropion-Lung12 Phase 3 Trial Begins For Datroway In NSCLC
30 Jan 2025 //
BUSINESSWIRE
Roche`s Itovebi pads its case with overall survival win
28 Jan 2025 //
REUTERS
Enhertu Approved in US for HER2-Low/Ultralow Breast Cancer
27 Jan 2025 //
BUSINESSWIRE
AstraZeneca Canadian investment to drive R&D growth
24 Jan 2025 //
EUROPEAN PHARMACEUTICAL REVIEW
AstraZeneca receives recommendations for lung cancer treatments
22 Jan 2025 //
PHARMATIMES
FDA Approves Acalabrutinib for Mantle Cell Lymphoma
17 Jan 2025 //
PRESS RELEASE
CDSCO approves AstraZeneca’s anti-complement medicine
17 Jan 2025 //
EXPRESSPHARMA
Datopotamab Deruxtecan Gets Priority Review For NSCLC Treatment
13 Jan 2025 //
BUSINESSWIRE
Synthego & AstraZeneca Sign CRISPR Gene Editing Enzyme Deal
13 Jan 2025 //
CONTRACTPHARMA
J&J`s combo extend patient` lives in study with AstraZeneca`s drug
08 Jan 2025 //
FIERCE PHARMA
Hutchmed`s Priority Review For Orpathys-Tagrisso In Lung Cancer
01 Jan 2025 //
GLOBENEWSWIRE
AstraZeneca India recasts biopharma unit
30 Dec 2024 //
ECONOMICTIMES
Volumes spurt at Astrazeneca Pharma India Ltd counter
30 Dec 2024 //
BUSINESS STD
What can AZ`s China probes teach other biopharma companies?
28 Dec 2024 //
FIERCE PHARMA
Datopotamab Deruxtecan Application in EU is Voluntarily Withdrawn
26 Dec 2024 //
BUSINESSWIRE
Achilles Announces Sale of Technology Assets to AstraZeneca
26 Dec 2024 //
GLOBENEWSWIRE
AstraZeneca withdraws application for lung cancer drug in EU
26 Dec 2024 //
REUTERS
LYNPARZA Demonstrates Prolonged Survival in Early Breast Cancer
11 Dec 2024 //
BUSINESSWIRE
PureTech Presents LYT-200 Data for AML/MDS at ASH 2024
09 Dec 2024 //
BUSINESSWIRE
Datopotamab Deruxtecan Gets Designation for EGFR-Mutated NSCLC
09 Dec 2024 //
BUSINESSWIRE
Employees` LinkedIn likes land AstraZeneca and GSK in hot water
06 Dec 2024 //
FIERCE PHARMA
IMFINZI® Granted Priority Review for Muscle-Invasive Bladder Cancer
06 Dec 2024 //
BUSINESSWIRE
AstraZeneca, Daiichi share data behind Dato-DXd do-over
06 Dec 2024 //
FIERCE BIOTECH
Pfizer’s Nurtec & Astrazeneca’s Breztri Top Digital Marketing Report
05 Dec 2024 //
BUSINESSWIRE
Datopotamab Shows Clinical Activity in EGFR-Mutated Lung Cancer
05 Dec 2024 //
BUSINESSWIRE
AstraZeneca chided after complainant targets senior staff
05 Dec 2024 //
FIERCE PHARMA
AstraZeneca names exec to take on role of detained China head
05 Dec 2024 //
REUTERS
FDA approves Imfinzi for limited-stage small cell lung cancer
05 Dec 2024 //
REUTERS
AstraZeneca`s Biologic Imfinzi Receives Suppl Approval in US
04 Dec 2024 //
FDA
AstraZeneca’s Enhertu Wins China Reimbursement Despite Probe
30 Nov 2024 //
BLOOMBERG
AstraZeneca asthma drug more effective during attack than steroids
30 Nov 2024 //
REUTERS
AstraZeneca’s Enhertu Wins China Reimbursement Despite Probe
28 Nov 2024 //
BLOOMBERG
AstraZeneca gets nod for sale, distribution of cancer drug Lynparza
27 Nov 2024 //
BUSINESS STD
AstraZeneca Pharma shares up on CDSCO nod for cancer drug Lynparza
27 Nov 2024 //
BUSINESS STD
AZ`s Truqap carves path in prostate cancer with phase 3 win
26 Nov 2024 //
PRESS RELEASE
AstraZeneca India to launch Breztri Aerosphere in Jan 2025
23 Nov 2024 //
INDPHARMAPOST
AstraZeneca cans ph. 2 OUD drug over antifungal interaction
23 Nov 2024 //
FIERCE BIOTECH
Global Coalition for Adaptive Research Evaluates AZD1390 in GBM Trial
22 Nov 2024 //
PR NEWSWIRE
AstraZeneca cans ph. 2 OUD drug over antifungal interaction
22 Nov 2024 //
FIERCE BIOTECH
FDA raises safety flags ahead of adcomm for AZ`s Andexxa
20 Nov 2024 //
FIERCE PHARMA
AstraZeneca Awards $3.5M for US Healthcare Access Projects
20 Nov 2024 //
BUSINESSWIRE
NICE says AZ, Daiichi failed to propose fair price on Enhertu
19 Nov 2024 //
FIERCE PHARMA
AstraZeneca Pharma to launch COPD drug in Jan 2025; stock up 3%
19 Nov 2024 //
BUSINESS STD
AstraZeneca Pharma gains on plan to launch COPD drug
19 Nov 2024 //
BUSINESS STD
Lunit Collaborates with AstraZeneca on AI Pathology Tools
18 Nov 2024 //
PR NEWSWIRE
AstraZeneca India, Academy of Paediatrics Raise RSV Awareness
14 Nov 2024 //
EXPRESSPHARMA
